UBS lowered the firm’s price target on Cogent (CCOI) to $21 from $27 and keeps a Neutral rating on the shares. The firm cites the company’s more moderate growth in waves for the target cut. It reduced estimates post the earnings report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCOI:
- Cogent’s Use of ARIN RPKI Boosts Routing Security but Adds New Systemic Risks, Analyst Warns
- Cogent reports Q4 EPS (64c), consensus ($1.09)
- Cogent price target lowered to $22 from $25 at Goldman Sachs
- Options Volatility and Implied Earnings Moves Today, February 20, 2026
- Cogent price target lowered to $52 from $55 at TD Cowen